Navigation Links
Us TOO Launches National 'SEA Blue' Campaign for Prostate Cancer Awareness Month
Date:8/30/2007

'As Pink is to Breast Cancer, Blue is to Prostate Cancer'

DOWNERS GROVE, Ill., Aug. 30 /PRNewswire-USNewswire/ -- In conjunction with September as prostate cancer awareness month, Us TOO International, the prostate cancer support organization is launching its nationwide "SEA Blue" campaign on behalf of prostate cancer patients and their families. SEA stands for support, education and advocacy -- the primary components of Us TOO's mission.

"The SEA Blue campaign is designed to reach out to those at risk, promote prostate cancer screening, and give a voice in the community to the issue of prostate cancer awareness," said Thomas Kirk, Us TOO president and CEO.

"Prostate cancer actually strikes more men than breast cancer does women each year, yet the public remains largely unaware of this serious health issue and the significance of the blue ribbon. We think it's important, in recognition of prostate cancer awareness month, for everyone to 'see blue' and realize that, as pink is to breast cancer -- blue is to prostate cancer," Kirk said.

Us TOO's "SEA Blue" campaign is being supported by information materials, lapel pins, window stickers and posters that the organization is distributing to its more than 300 local chapters around the country. The "SEA Blue" materials can also be obtained by visiting Us TOO's Web site http://www.ustoo.org, or by calling 1 (800) 808-7866.

"Us TOO is committed to helping men and their families learn more about prostate cancer during prostate cancer awareness month and throughout the entire year, so they can make better decisions on treatment options and cope with emotional and quality of life issues following treatment," said Us TOO chairman Jim Kiefert.

"We're hopeful that, as more Americans understand why it's important to 'see blue' in the same way that they 'see pink,' there will be a groundswell of support for prostate cancer patients," K
'/>"/>

SOURCE Us TOO International
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Pfizer Launches Viagra For Lung Disease In UK
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Hundreds of Risperdal lawsuits ... individuals who allegedly suffered gynecomastia (male breast growth) ... the antipsychotic drug continue to move forward in ... Philadelphia Court of Common Pleas. According to court ... trial program, as the third trial involving Risperdal’s ...
(Date:5/27/2015)... Texas (PRWEB) May 27, 2015 In ... are getting tighter, it can be challenging for doctors ... for cutting edge treatments. , Austin-based HealthTronics, ... with minimally invasive, mobile medical therapies for clinically sophisticated ... portfolio with the acquisition of Laser Ventures, Inc ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ... for enterprise organizations, announced today that SanMar Corporation ... its time, attendance and point tracking processes for ... United States. , Family-owned since 1971, Seattle-based ... retail, private label, and mill brands. SanMar supplies ...
(Date:5/27/2015)... Little Rock, AR (PRWEB) May 27, 2015 ... and Medix today announce a partnership to provide ... the Medix community. This collaboration seeks to strengthen ... skills measurement through CMSA’s CKP program. The mutually ... focused on identifying individual skills of talent in ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CompanionDx ... pharmacogenomic and somatic genomic analysis in personalized cancer therapy: ... by the American Society of Clinical Oncology (ASCO) as ... 2 in Chicago. , The molecular and clinical data ... Genome Atlas (TCGA) database. The study reports improved patient ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3
... Ltd, a Pune-based company have jointly come out with ... this at a press conference here on Thursday,// NCL ... the chirally pure S-Amlodipine, a product of their collaborative ... suffering from hypertension. ,Stating that Emcure is ...
... that has receive only a little scientific interest and virtually ... and respiratory health. A study of over 2,000 children ... issue. The study appeared in the January 15, 2002 ... and potassium intakes were associated with lower lung function. ...
... company has finalized development of a digital screening ... of diagnosing melanomas, the third most common cancer ... said that in terms of its ability to ... analysis and computer-aided diagnostic software for SolarScan, which ...
... France observed in a study that red wine drinkers ... "good" cholesterol. This helps show some light on why ... disease. // ,Researchers compared HDL cholesterol levels between ... who are regular drinkers and those who are heavy ...
... at the University of Michigan, made a new study ... patients after head and neck surgery. Ann Arbor say leeches ... who have surgery// to remove cancer in and around the ... ,Doctors say about 15 percent of patients develop obstructions ...
... recall test is able to differentiate those who will get ... a condition of older people - so we can expect ... ages.// Treatments are now available and they seem to work ... a priority. ,Researchers at the University of Toronto ...
Cached Medicine News:Health News:Latest device for identifying Melanomas 2
(Date:5/27/2015)...  Actavis plc (NYSE: ACT ) announced ... Food and Drug Administration (FDA) as a twice-daily, ... syndrome with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed ... agonist, a delta receptor antagonist, and a kappa ... "The FDA,s approval of VIBERZI ...
(Date:5/27/2015)... May 27, 2015   Madison Laser Tattoo Removal ... Madison and the surrounding area to offer ... Madison Laser Tattoo Removal is dedicated to bringing a solution ... Wisconsin . "I founded Madison Laser Tattoo ... and return their skin to its natural look," said ...
(Date:5/27/2015)...  Sequenom, Inc. (NASDAQ: SQNM ), a life ... development of innovative products and services, today announced that ... laboratory operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier ... North Carolina laboratory location.  ...
Breaking Medicine Technology:Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 3Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 4Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 5Madison Laser Tattoo Removal Brings Superior Laser Tattoo Removal Services To Madison, WI With Astanza Duality 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
... product designed for LASIK surgery and ... to irrigate the corneal interface and/or ... insertion under the flap and helps ... provide multi-directional irrigation.27G x 7/8in (.40 ...
... designed for LASIK surgery and other types ... corneal interface and/or stromal bed. Flattened tip ... helps elevate the flap edge. Multiple ports ... x 22mm) Formed 7mm from end. Two ...
... Unique product designed for LASIK ... surgery. Designed to irrigate the corneal ... provides easy insertion under the flap ... Multiple ports provide multi-directional irrigation. 21G ...
Medicine Products: